We Offer Worldwide Shipping
Login Wishlist

20(R)-Ginsenoside Rg2

$476

  • Brand : BIOFRON

  • Catalogue Number : BD-P0617

  • Specification : 98.0%(HPLC)

  • CAS number : 80952-72-3

  • Formula : C42H72O13

  • Molecular Weight : 785.02

  • PUBCHEM ID : 157711

  • Volume : 20mg

Available on backorder

Quantity
Checkout Bulk Order?

Catalogue Number

BD-P0617

Analysis Method

Specification

98.0%(HPLC)

Storage

-20℃

Molecular Weight

785.02

Appearance

Powder

Botanical Source

This product is isolated and purified from the roots of Panax ginseng C. A. Mey.

Structure Type

Category

SMILES

CC1C(C(C(C(O1)OC2C(C(C(OC2OC3CC4(C(CC(C5C4(CCC5C(C)(CCC=C(C)C)O)C)O)C6(C3C(C(CC6)O)(C)C)C)C)CO)O)O)O)O)O

Synonyms

(S)Ginsenoside Rg2/20(R)-Ginsenoside Rg2/β-D-Glucopyranoside, (3β,6α,12β,20R)-3,12,20-trihydroxydammar-24-en-6-yl 2-O-(6-deoxy-α-L-mannopyranosyl)-/Ginsenoside-Rg2/(3β,6α,12β,20R)-3,12,20-Trihydroxydammar-24-en-6-yl 2-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranoside/20(R)Ginsenoside Rg2

IUPAC Name

Applications

Density

1.3±0.1 g/cm3

Solubility

Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc.

Flash Point

486.6±34.3 °C

Boiling Point

881.0±65.0 °C at 760 mmHg

Melting Point

InChl

InChl Key

AGBCLJAHARWNLA-TZTDDQMKSA-N

WGK Germany

RID/ADR

HS Code Reference

Personal Projective Equipment

Correct Usage

For Reference Standard and R&D, Not for Human Use Directly.

Meta Tag

provides coniferyl ferulate(CAS#:80952-72-3) MSDS, density, melting point, boiling point, structure, formula, molecular weight etc. Articles of coniferyl ferulate are included as well.>> amp version: coniferyl ferulate

No Technical Documents Available For This Product.

PMID

31257804

Abstract

OBJECTIVE:
To investigate the effects of ginsenoside-Rg2 on mechanical allodynia, heat hyperalgeia, depressive state of rats with chronic sciatic nerve constriction injury.

METHODS:
Fifty SD rats were randomly divided into 5 groups: blank control group (Normal, normal + saline),sham operation group (Sham, sham operation + saline),chronic constriction injury of the sciatic nerve group (CCI, CCI + saline),ginsenoside-Rg2 low dose group (CCI + Rg2 5 mg/kg), and ginsenoside-Rg2 high dose group (CCI + Rg2 10 mg/kg).After the CCI model was established,drug were injected into the abdominal cavity through the syringe once a day,for 14 consecutive days.The mechanical shrinkage foot reflex threshold (MWT) and thermal withdrawal latency(TWL) were determined at 1 d before the operation and at 1,3,5,7,10 and 14 d after the operation.Light-dark transition test, forced swimming test were determined at 1 d before the operation and at 14 d after the operation.

RESULTS:
Compared with the sham group, the MWL and TWL of the CCI rats were decreased significantly (P<0.01), time in the light compartment and number of transition were decreased (P<0.01), the immobility time in FST was also prolonged significantly (P<0.01). At 14 days after CCI operation, the MWL and TWL of the ginsenoside-Rg2 groups were increased significantly (P<0.01), time in the light compartment and number of transition were also shortened significantly (P<0.01), the immobility time in FST was also shortened significantly (P<0.01).

CONCLUSION:
Intraperitoneal injection of ginsenoside-Rg2 can inhibit the mechanical and thermal pain sensitivity of CCI rats,and can relieve depressive state.

Title

[Effects of ginsenoside-Rg2 on mechanical allodynia, heat hyperalgeia, depressive state of rats with chronic sciatic nerve constriction injury].

Author

Zhang QL1, Li SY1, Li P1.

Publish date

2019 May 28

PMID

31161181

Abstract

Ginsenoside Rg2 is one of the specific ginsenosides in red ginseng, and has been reported to exhibit protective effects against neurotoxicity and memory impairment, and also inhibition of hepatic glucose production. However, the effect of Rg2 on the prevention of obesity has not been investigated. In this study, we evaluated the anti-obesity and anti-adipogenic effects of Rg2 in high-fat diet-induced obese mice (HFD mice) and 3T3-L1 preadipocytes. Oral administration of Rg2 (10 mg kg-1) to HFD mice significantly decreased body weight gain, total triglycerides, and free fatty acid levels. In 3T3-L1 preadipocytes, Rg2 (80 μM) inhibited adipocyte differentiation and reduced the accumulation of intracellular lipids. Quantitative PCR and western blot analysis revealed that Rg2 decreased the expression levels of adipogenic transcription factors (PPARγ, C/EBPα, and SREBP1-c), and then regulated target genes such as acetyl-CoA carboxylase (ACC) and fatty acid synthase (FAS). Rg2 significantly promoted AMP-activated protein kinase (AMPK) both in vivo and in vitro, which is known to suppress adipogenesis. It was also found that pretreating with compound C, a typical inhibitor of AMPK, attenuated the inhibitory effect of Rg2 on AMPK phosphorylation. These findings suggested that Rg2-induced activation of AMPK leads to a decrease in the expression of adipogenic transcription factors, and suppression of adipogenesis in vivo and in vitro. Hence, Rg2 has the potential for the development of healthy foods and the prevention of obesity.

Title

Ginsenoside Rg2 inhibits adipogenesis in 3T3-L1 preadipocytes and suppresses obesity in high-fat-diet-induced obese mice through the AMPK pathway.

Author

Liu H 1, Liu M , Jin Z , Yaqoob S , Zheng M , Cai D , Liu J , Guo S .

Publish date

2019 Jun 19

PMID

28842305

Abstract

Major depression is a common neuropsychiatric disease with high lifetime prevalence and high incidence of suicide. This study aimed to evaluate the antidepressant effects of ginsenoside Rg2 in mice, and the possible mechanism was also determined. A single injection of both Rg2 (10 and 20mg/kg) and fluoxetine (positive control, 20mg/kg) induced notable antidepressant-like effects in the forced swim test and tail suspension test without affecting the locomotor activity of mice, and the tests were done 30min after the injection. Also, repeated daily treatment of Rg2 and fluoxetine for the last 2 weeks fully reversed the chronic mild stress (6 weeks)-induced depressive-like symptoms in mice. Moreover, western blot analysis showed that Rg2 administration significantly increased the BDNF signaling pathway in hippocampus. Importantly, the usage of TrkB shRNA fully blocked the antidepressant effects of Rg2 in mice. Collectively, these results suggest that Rg2 produces an antidepressant-like effect in mice which is mediated, at least in part, through promoting the hippocampal BDNF signaling pathway.

Copyright © 2017 Elsevier Inc. All rights reserved.

KEYWORDS

Brain-derived neurotrophic factor; Chronic mild stress; Depression; Ginsenoside Rg2

Title

Antidepressant-like effects of ginsenoside Rg2 in a chronic mild stress model of depression.

Author

Ren Y1, Wang JL2, Zhang X1, Wang H2, Ye Y1, Song L2, Wang YJ2, Tu MJ1, Wang WW1, Yang L1, Jiang B3.

Publish date

2017 Sep